Life Science / Pharma & Chemicals – Selected Transactions

IEP GmbH, headquartered in Wiesbaden, Germany, develops customised enzyme processes. Using its “green” technology, IEP optimizes the complex production processes found in pharmaceutical small molecular ingredients. The firm supplies mainly large and middle-sized pharmaceutical companies. IEP possesses excellent interdisciplinary expertise in biochemistry, molecular biology and chemistry, as well as owning a portfolio of over 100 enzymes, and has highly innovative and patented know-how. C▪H▪Reynolds successfully advised the investor on the sale of their shares to Cambrex Corporation. Read more…